U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H16O5
Molecular Weight 324.3273
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 7-HYDROXYWARFARIN, (R)-

SMILES

CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=C(O)C=C3

InChI

InChIKey=SKFYEJMLNMTTJA-OAHLLOKOSA-N
InChI=1S/C19H16O5/c1-11(20)9-15(12-5-3-2-4-6-12)17-18(22)14-8-7-13(21)10-16(14)24-19(17)23/h2-8,10,15,21-22H,9H2,1H3/t15-/m1/s1

HIDE SMILES / InChI

Description

R-7-hydroxywarfarin belongs to the family of Chromones. R-7-Hydroxywarfarin is a metabolite of Warfarin. R-7-Hydroxywarfarin is only found in individuals that have used or taken Warfarin.

Approval Year

Unknown
139594
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Effects of etravirine on the pharmacokinetics and pharmacodynamics of warfarin in rats.
2013 Apr
Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors.
2015 Jun
Patents

Patents

US20100273203
2
WO2003059351A1
1

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
7-HYDROXYWARFARIN, (R)-
Common Name English
7-HYDROXY-R-WARFARIN
Common Name English
2H-1-BENZOPYRAN-2-ONE, 4,7-DIHYDROXY-3-((1R)-3-OXO-1-PHENYLBUTYL)-
Systematic Name English
R-7-HYDROXYWARFARIN
Common Name English
(R)-7-HYDROXYWARFARIN
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID30716389
Created by admin on Sat Dec 16 09:45:12 GMT 2023 , Edited by admin on Sat Dec 16 09:45:12 GMT 2023
PRIMARY
PUBCHEM
54732122
Created by admin on Sat Dec 16 09:45:12 GMT 2023 , Edited by admin on Sat Dec 16 09:45:12 GMT 2023
PRIMARY
FDA UNII
U8GT4FIF2T
Created by admin on Sat Dec 16 09:45:12 GMT 2023 , Edited by admin on Sat Dec 16 09:45:12 GMT 2023
PRIMARY
CAS
63740-76-1
Created by admin on Sat Dec 16 09:45:12 GMT 2023 , Edited by admin on Sat Dec 16 09:45:12 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966